ARTICLE | Company News
InterMune Pharmaceuticals Inc., Boehringer Ingleheim GmbH deal
October 22, 2001 7:00 AM UTC
The companies expanded their March deal for ITMN to develop and market interferon gamma-1b for multiple indications under Boehringer's trade name Imukin in all countries outside of the U.S., Canada an...